From GlobeNewswire: 2025-05-23 01:10:00

Roche has announced a strategic collaboration with Broad Clinical Labs to develop applications using Roche’s SBX sequencing technology, focusing on critically ill newborns. The partnership aims to establish whole genome sequencing as routine clinical practice for newborns and explore its use in research applications. Specifically, the project will advance trio-based whole genome sequencing of newborns and their parents to enable precise diagnoses and improved outcomes for infants with suspected genetic disorders. The SBX technology offers ultra-fast sequencing, high scalability, and cost efficiency for various sequencing applications, including RNA sequencing. This collaboration aligns with both organizations’ commitment to advancing precision medicine at scale. Roche partners with Broad Clinical Labs to use SBX sequencing technology for critically ill newborns and parents. Whole genome sequencing aids in diagnosing genetic disorders like cystic fibrosis and sickle cell disease. The collaboration aims to integrate this technology into routine clinical practice for newborns and explore its use in other research areas.



Read more at GlobeNewswire: Roche announces new collaboration with Broad Clinical Labs